Suheung Co., Ltd. (KRX:008490)
26,250
+400 (1.55%)
At close: Nov 4, 2025
Suheung Revenue
Suheung had revenue of 190.02B KRW in the quarter ending June 30, 2025, with 9.99% growth. This brings the company's revenue in the last twelve months to 686.02B, up 10.01% year-over-year. In the year 2024, Suheung had annual revenue of 653.26B with 9.87% growth.
Revenue (ttm)
686.02B
Revenue Growth
+10.01%
P/S Ratio
0.43
Revenue / Employee
924.56M
Employees
742
Market Cap
291.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 653.26B | 58.70B | 9.87% |
| Dec 31, 2023 | 594.57B | -40.40B | -6.36% |
| Dec 31, 2022 | 634.97B | 38.23B | 6.41% |
| Dec 31, 2021 | 596.73B | 43.72B | 7.91% |
| Dec 31, 2020 | 553.01B | 92.28B | 20.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.03T |
| Celltrion | 3.75T |
| Yuhan | 2.17T |
| Hanmi Pharm. | 1.47T |
| SK Biopharmaceuticals | 620.28B |
| PharmaResearch | 449.81B |
| Sam Chun Dang Pharm. | 215.10B |
| ALTEOGEN | 158.06B |